| LDR | 01281nam a22003251p 4500 | ||
| 001 | 001556766 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 891207s1972 enka b 10110 eng o | ||
| 010 | ⊔ | ⊔ | ‡a75189931 |
| 015 | ⊔ | ⊔ | ‡aB72-17347 |
| 020 | ⊔ | ⊔ | ‡a0126408661 : ‡c£4.00 |
| 035 | ⊔ | ⊔ | ‡a(MiU)990015567660106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990015567660106381 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)483465 |
| 035 | ⊔ | ⊔ | ‡a(SAZTEC)117501700 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)175784024 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph001556766 |
| 050 | ⊔ | ⊔ | ‡aQR360 ‡b.V526 |
| 082 | ⊔ | ⊔ | ‡a616.01/94 |
| 245 | 0 | 0 | ‡aVirus-cell interactions and viral antimetabolites : ‡b[proceedings of Symposium no. 3 of the] seventh meeting [of the] Federation of European Biochemical Societies, Varna (Bulgaria), September 1971 / ‡cedited by D. Shugar. |
| 260 | ⊔ | ⊔ | ‡aLondon : ‡b(24 Oval Rd., N.W.1) ; ‡aNew York : ‡bAcademic Press, ‡c1972. |
| 300 | ⊔ | ⊔ | ‡aviii, 231 p. : ‡billus. ; ‡c24 cm. |
| 490 | 0 | ⊔ | ‡aFEBS symposium, v. 22 |
| 490 | 0 | ⊔ | ‡aSeventh FEBS meeting [v. 1] |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographical references. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aAntiviral agents ‡vCongresses. |
| 650 | ⊔ | 0 | ‡aHost-virus relationships ‡vCongresses. |
| 700 | 1 | ⊔ | ‡aShugar, D. ‡q(David) |
| 710 | 2 | ⊔ | ‡aFederation of European Biochemical Societies. |
| CID | ⊔ | ⊔ | ‡a001556766 |
| DAT | 0 | ⊔ | ‡a19960229000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210927140731.0 ‡b2023-07-19T17:32:44Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990015567660106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015003213520 ‡sMIU ‡1990015567660106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230719 ‡sgoogle ‡umdp.39015003213520 ‡y1972 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929 |